...
Related Posts on
Before the January 20th inauguration, the senate voted on a budget that would allow the repeal of the Affordable Care Act. On January 20th as president, Trump’s first...
Reading opinion pieces about what is driving the high costs of health care is like listening to siblings squabble about who is getting a dying parent’s money: each stakeholder claims to be getting...
Pharmaceutical manufacturers received good news this month when president-elect Donald Trump won and “breathed new life into troubled industries, like Big Pharma stocks” according to a recent...
I learned the word telenovela—which means soap opera in Spanish—in February when I aspired to passively learn Spanish while being entertained by bad acting. I immersed myself in a show ...
Speaking of hurricanes, tis the season and here’s another more menacing to the pharmaceutical industry than MACRA, which I discussed...
For more than a year, preparations for Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) has been like a recently named Cat 5 hurricane brewing off the edge of a fragile coastline. Some...
Those who travel to southeast Asia will likely hear the phrase “Same Same But Different” which, among other uses, is commonly said by market vendors trying to sell a knock-off of a brand name item...
Today, Novartis officially launched the highly anticipated first U.S. biosimilar, ZARXIO. ZARXIO was approved for the...
The 2016 formulary exclusion lists have been announced by CVS Caremark and Express Scripts. The lists feature additional product removals in 2016, with Express Scripts increasing its list of...